SEC Form 4 · accession 0001179110-15-006171
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theresa McNeely
Officer — EVP, Chief Comm. Officer
Period of report
Apr 8, 2015
Accepted (ET)
Apr 9, 2015 · 1:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2015 | P | 174 | $28.79 | A | 174 | D | |
| Common Stock | Apr 9, 2015 | P | 226 | $29.68 | A | 400 | D |
Table II — derivative securities
No Table II lines on this filing.